URMC-099

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2013-2018
012320132018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The mixed lineage kinase type 3 inhibitor URMC-099 facilitates amyloid-beta (Aβ) clearance and degradation in cultured murine… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2017
2017
Long-acting anti-HIV products can substantively change the standard of care for patients with HIV/AIDS. To this end, hydrophobic… (More)
  • figure 1
  • figure 3
  • figure 6
  • figure 7
  • figure 8
Is this relevant?
2016
2016
During studies to extend the half-life of crystalline nanoformulated antiretroviral therapy (nanoART) the mixed lineage kinase-3… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Amyloid-β (Aβ)-stimulated microglial inflammatory responses engage mitogen-activated protein kinase (MAPK) pathways in Alzheimer… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2016
2016
C-X-C Motif Ligand 10–Bearing Chemotactic Extracellular Vesicles From Lipotoxic Hepatocytes” (volume 63, pages 731-734; doi: 10… (More)
Is this relevant?
2013
2013
Human immunodeficiency virus (HIV)-associated neurocognitive disorders (HAND) is a significant source of disability in the HIV… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2013
2013
Inhibition of mixed lineage kinase 3 (MLK3) is a potential strategy for treatment of Parkinson's disease and HIV-1 associated… (More)
Is this relevant?